Experience: Has significant experience from leading positions and board roles in the pharmaceutical, biotech and MedTech industries with several senior positions in AstraZeneca.
Current assignments: Chariman of i Chosa Oncology AB and Strominnate AB. Board member of Asgard Therapeutics AB, Cell Invent AB, Vagnlyftaren AB and Ventac Partners AB.
Previous assignments: Chariman of IAmPatient AB, Scandinavian ChemoTech AB and Vetiqure AB. Board member of Hamlet Pharma AB. Alternate board member of CanImGuide Therapeutics AB and Immodulate Pharma AB. CEO of RhoVac AB, Idogen AB and Pharmiva AB.
Shareholding: 365,000
Independent in relation both to the Company and its management, as well as to major shareholders.
